Expression and Prognostic Role of CXCR4/CXCL12/CXCR7 and mTOR Pathways in Neuroendocrine Tumors (NETs)

被引：0
|
作者：
Circelli, L. [1 ]
Sciammarella, C. [2 ]
Faggiano, A. [2 ]
Tafuto, S. [1 ]
Pezzullo, L. [1 ]
Guadagno, E. [2 ]
De Caro, Del Basso M. L. [2 ]
Tatangelo, F. [1 ]
Losito, N. S. [1 ]
Izzo, F. [1 ]
Scala, S. [1 ]
Colao, A. [2 ]
机构：
[1] Fdn G Pascale, Natl Canc Inst, Naples, Italy
[2] Univ Naples Federico II, Naples, Italy
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
chemokine; mtor; nets; clinical outcome;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A4
引用
收藏
页码：222 / 222
页数：1
相关论文
共 50 条
  • [31] CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12
    Carvalho Melo, Rita de Cassia
    Longhini, Ana Leda
    Bigarella, Carolina Louzao
    Baratti, Mariana Ozello
    Traina, Fabiola
    Favaro, Patricia
    Campos, Paula de Melo
    Olalla Saad, Sara Teresinha
    PLOS ONE, 2014, 9 (01):
  • [32] An Infernal Trio: The chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology
    Hattermann, Kirsten
    Mentlein, Rolf
    ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 2013, 195 (02) : 103 - 110
  • [33] Biological relevance of Chemokine Receptors CXCR4 and CXCR7 and their ligand CXCL12 in Osteosarcoma Metastasis
    Brennecke, P.
    Arlt, M.
    Born, W.
    Fuchs, B.
    SWISS MEDICAL WEEKLY, 2010, 140 (23-24) : 40S - 40S
  • [34] The expression and biological function of chemokine CXCL12 and receptor CXCR4/CXCR7 in placenta accreta spectrum disorders
    Long, Yu
    Jiang, Yonghua
    Zeng, Jingjing
    Dang, Yiwu
    Chen, Yue
    Lin, Jueying
    Wei, Hongwei
    Xia, Hongwei
    Long, Junqing
    Luo, Cuizhen
    Chen, Zhiwei
    Huang, Yaling
    Li, MuJun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (05) : 3167 - 3182
  • [35] Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma
    Masakazu Goto
    Yukiko Shibahara
    Cristina Baciu
    Frances Allison
    Jonathan C. Yeung
    Gail E. Darling
    Mingyao Liu
    Annals of Surgical Oncology, 2021, 28 : 4943 - 4951
  • [36] Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma
    Goto, Masakazu
    Shibahara, Yukiko
    Baciu, Cristina
    Allison, Frances
    Yeung, Jonathan C.
    Darling, Gail E.
    Liu, Mingyao
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 4943 - 4951
  • [37] Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
    Singh, Anup Kumar
    Arya, Rakesh Kumar
    Trivedi, Arun Kumar
    Sanyal, Sabyasachi
    Baral, Rathindranath
    Dormond, Olivier
    Briscoe, David M.
    Datta, Dipak
    CYTOKINE & GROWTH FACTOR REVIEWS, 2013, 24 (01) : 41 - 49
  • [38] CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma
    Werner, Thomas A.
    Forster, Christina M.
    Dizdar, Levent
    Verde, Pablo E.
    Raba, Katharina
    Schott, Matthias
    Knoefel, Wolfram T.
    Krieg, Andreas
    BRITISH JOURNAL OF CANCER, 2017, 117 (12) : 1837 - 1845
  • [39] CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma
    Thomas A Werner
    Christina M Forster
    Levent Dizdar
    Pablo E Verde
    Katharina Raba
    Matthias Schott
    Wolfram T Knoefel
    Andreas Krieg
    British Journal of Cancer, 2017, 117 : 1837 - 1845
  • [40] Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma
    Barbieri, Federica
    Bajetto, Adriana
    Thellung, Stefano
    Wuerth, Roberto
    Florio, Tullio
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (11) : 1093 - 1109
12345